treatment options - United Kingdom News Beep

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

August 19, 2026

Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…

HHealth

‘I’m a GP — we should all know the signs of this condition'

July 14, 2026

Endometriosis affects around 1.5 million women in the UK (Image: Humphrey Nemar/Getty) Endometriosis is one of the commonest…

HHealthcare

WHO warns global cancer cases could nearly double by 2050

July 8, 2026

The World Health Organization (WHO) said on Wednesday that the number of new cancer cases diagnosed worldwide each…

MMedication

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

December 9, 2025

Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target…